IRIS Accounts Production v26.1.10.61 09930112 director 1.1.25 31.12.25 31.12.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099301122024-12-31099301122025-12-31099301122025-01-012025-12-31099301122023-12-31099301122024-01-012024-12-31099301122024-12-3109930112ns15:EnglandWales2025-01-012025-12-3109930112ns14:PoundSterling2025-01-012025-12-3109930112ns10:Director12025-01-012025-12-3109930112ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3109930112ns10:SmallEntities2025-01-012025-12-3109930112ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3109930112ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3109930112ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3109930112ns10:FullAccounts2025-01-012025-12-3109930112ns10:RegisteredOffice2025-01-012025-12-3109930112ns5:CurrentFinancialInstruments2025-12-3109930112ns5:CurrentFinancialInstruments2024-12-3109930112ns5:ShareCapital2025-12-3109930112ns5:ShareCapital2024-12-3109930112ns5:RetainedEarningsAccumulatedLosses2025-12-3109930112ns5:RetainedEarningsAccumulatedLosses2024-12-3109930112ns5:FurnitureFittings2024-12-3109930112ns5:FurnitureFittings2025-01-012025-12-3109930112ns5:FurnitureFittings2025-12-3109930112ns5:FurnitureFittings2024-12-3109930112ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3109930112ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31
REGISTERED NUMBER: 09930112 (England and Wales)










Unaudited Financial Statements

for the Year Ended 31 December 2025

for

Theranos Real Estate Limited

Theranos Real Estate Limited (Registered number: 09930112)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Theranos Real Estate Limited

Company Information
for the Year Ended 31 December 2025







DIRECTOR: D Guha





REGISTERED OFFICE: Unit 4 72 London Road
Southampton
Hampshire
England
SO15 2AJ





REGISTERED NUMBER: 09930112 (England and Wales)





ACCOUNTANTS: RAA Gaglani & Co Ltd
Suite 15 The Enterprise Centre
Coxbridge Business Park
Farnham
Surrey
GU10 5EH

Theranos Real Estate Limited (Registered number: 09930112)

Balance Sheet
31 December 2025

2025 2024
Notes £    £   
Fixed assets
Tangible assets 5 2,448 3,264

Current assets
Debtors 6 549,912 278,989
Cash at bank 1,327,099 1,222,667
1,877,011 1,501,656
Creditors: amounts falling due within one
year

7

(1,444,325

)

(1,363,813

)
Net current assets 432,686 137,843
Total assets less current liabilities 435,134 141,107

Capital and reserves
Called up share capital 1 1
Retained earnings 435,133 141,106
Shareholders' funds 435,134 141,107

Theranos Real Estate Limited (Registered number: 09930112)

Balance Sheet - continued
31 December 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 July 2026 and were signed by:





D Guha - Director


Theranos Real Estate Limited (Registered number: 09930112)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Theranos Real Estate Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
The financial statements have been prepared under the historical cost convention.

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The company's functional and presentational currency is pound sterling.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES
The principal accounting policies applied in the preparation of these financial statements are set out below.
These policies have been consistently applied to all the years presented, unless otherwise stated.

GOING CONCERN
The financial statements have been prepared on a going concern basis.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

DEPRECIATION
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset classDepreciation method and rate
Fixtures & fittings25% reducing balance basis


Theranos Real Estate Limited (Registered number: 09930112)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

3. ACCOUNTING POLICIES - continued
TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

DEFINED CONTRIBUTION PENSION OBLIGATION
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 January 2025
and 31 December 2025 36,445
DEPRECIATION
At 1 January 2025 33,181
Charge for year 816
At 31 December 2025 33,997
NET BOOK VALUE
At 31 December 2025 2,448
At 31 December 2024 3,264

Theranos Real Estate Limited (Registered number: 09930112)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 549,912 278,989

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 15,168 15,168
Corporation tax 98,281 44,012
VAT 12,420 14,106
Landlords Control Account 1,020,753 1,020,753
Directors' current accounts 297,454 269,565
Accruals and deferred income 249 209
1,444,325 1,363,813